Kaliszewski K,
Diakowska D,
Ziętek M,
Knychalski B,
Aporowicz M,
Sutkowski K,
Wojtczak B.
Thyroid incidentaloma as a "PAIN" phenomenon- does it always require surgery? Medicine (Baltimore).
2018 Dec;97(49).
Sager S,
Vatankulu B,
Sahin OE,
Cınaral F,
Uslu L,
Baran A,
Ozturk T,
Sönmezoglu K.
Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. J Cancer Res Ther.
2018 Jul-Sep;14(5):989-993.
Makis W,
Ciarallo A.
Thyroid Incidentalomas on 18F-FDG PET/CT: Clinical Significance and Controversies.
Mol Imaging Radionucl Ther.
2017 Oct 3;26(3):93-100.
Demir Ö,
Köse N,
Özkan E,
Ünlütürk U,
Aras G,
Erdoğan MF.
Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Nucl Med Commun.
2016 Jul;37(7):715-20.
Chung SR,
Choi YJ,
Suh CH,
Kim HJ,
Lee JJ,
Kim WG,
Sung TY,
Lee YM,
Song DE,
Lee JH,
Baek JH.
Thyroid Incidentalomas Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography: Malignant Risk Stratification and Management Plan.Thyroid.
2018 Jun;28(6):762-768.
Şencan Eren M,
Özdoğan Ö,
Gedik A,
Ceylan M,
Güray Durak M,
Seçil M,
Koçdor MA,
Çömlekçi A,
Durak H.
The incidence of 18F-FDG PET/CT thyroid incidentalomas and the prevalence of malignancy: a prospective study.
Turk J Med Sci.
2016 Apr 19;46(3):840-7.
Chun AR,
Jo HM,
Lee SH,
Chun HW,
Park JM,
Kim KJ,
Jung CH,
Mok JO,
Kang SK,
Kim CH,
Kim BY.
Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
Endocrinol Metab (Seoul).
2015 Mar 27;30(1):71-7.
Achury C,
Estorch M,
Domènech A,
Camacho V,
Flotats A,
Jaller R,
Geraldo L,
Deportós J,
Montes A,
Carrió I.
Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies.Rev Esp Med Nucl Imagen Mol.
2014 Jul-Aug;33(4):205-9.